Elizabeth Robertson and Rachel Connor on immunotherapies, screening and the next era of type 1 diabetes research
Watch the full video on YouTube.
In this episode, Elizabeth Robertson (Diabetes UK) and Rachel Connor (Breakthrough T1D) discuss one of the most exciting developments in diabetes research: the growing possibility of delaying and ultimately preventing type 1 diabetes.
Topics discussed include:
The rapid progress of immunotherapies for type 1 diabetes
Why early screening is becoming increasingly important
The ELSA study and identifying people at risk before clinical diagnosis
Stem cell-derived beta cell therapies and the latest clinical trials
How charities accelerate research through funding and international collaboration
The importance of ensuring new therapies reach people through healthcare systems and policy
For more content from previous episodes, visit our podcast archive.
